Immunotherapy wipes out some colorectal tumors without surgery, signaling a major shift toward less invasive treatment.

Daraxonrasib belongs to a new class of medicines known as RAS(ON) inhibitors. The drug targets the active form of RAS ...

A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 ...

Women taking the drug tell the BBC it has given them their lives back.

A new targeted ovarian cancer treatment is helping women with hard-to-treat disease live longer, feel better, and gain ...

Around 97% of patients with advanced pancreatic cancer die within five years. Researchers have figured out a way to target ...

Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have more reason to hope than ever before.

A breakthrough targeted therapy, mirvetuximab soravtansine, is offering new hope to women with hard-to-treat ovarian cancer.

The study showed that an experimental pill from the company Revolution Medicines almost doubled metastatic pancreatic cancer patients’ survival times compared with chemotherapy.

A new era in the treatment of deadly pancreatic cancer was heralded by scientists this week, thanks to science by the ...

Experts have hailed the ‘landmark’ decision from the National Institute for Health and Care Excellence to approve the ...